Moderna is seeking US approval for a COVID vaccine for children under the age of six
Moderna, a US biotech company, announced on Thursday that it had submitted an emergency use authorisation request in the US for its COVID vaccination for children aged six months to under six years.
In the United States and most other nations, children under the age of six are the only age group that has yet to get a COVID-19 vaccine.
"We believe (this vaccine) will be able to safely protect these children against SARS-CoV-2, which is so important in our continued fight against COVID-19 and will be especially welcomed by parents and caregivers," Stephane Bancel, the company's CEO, stated in a statement.
The business stated in March that the two-shot regimen was determined to be safe and produced a significant immunological response in a trial.
Two doses of 25 micrograms giv...